Related Experiment Videos
Mechanisms of drug actions against neuronal damage caused by ischemia--an overview
1Institut für Pharmakologie und Toxikologie, Fachbereich Pharmazie und Lebensmittelchemie, Philipps-Universität Marburg, Lahn, Germany.
Abstract:
1. Oxygen and energy deficits induces a cascade of pathological processes which lead to neuronal dysfunction and cell death. 2. The pathogenesis of ischemia-induced neuronal damage includes a disturbed calcium homeostasis, an excessive release of EAA and an enhanced formation of free oxygen radicals. 3. Calcium antagonists inhibit Ca2+ influx into the neuronal cell via VSCC. 4. Glutamate antagonists reduce intracellular Ca2+ concentration by inactivation of NMDA receptor-associated calcium channels (NMDA antagonists) or AMPA/quisqualate receptor-linked sodium channels (non-NMDA antagonists). 5. Furthermore, oxygen radical scavengers can avoid neuronal damage. 6. Agonists of the adenosinergic and serotonergic transmitter systems contribute to neuroprotection by hyperpolarization of the neuronal membrane due to an increase of K+ permeability.
Insights
Neuroprotective strategies combat neuronal death from oxygen and energy deficits. Therapies targeting calcium homeostasis, excitotoxicity, and oxidative stress offer promising neuroprotection against ischemic damage.
Area of Science:
- Neuroscience
- Cell Biology
- Pathophysiology
Background:
- Oxygen and energy deficits trigger pathological processes leading to neuronal dysfunction and death.
- Ischemia-induced neuronal damage involves disrupted calcium homeostasis, excessive excitatory amino acid (EAA) release, and free radical formation.
Purpose of the Study:
- To explore neuroprotective mechanisms against ischemia-induced neuronal damage.
- To investigate the role of calcium antagonists, glutamate antagonists, oxygen radical scavengers, and neurotransmitter systems in neuroprotection.
Main Methods:
- Inhibition of calcium influx using calcium antagonists targeting voltage-sensitive calcium channels (VSCC).
- Reduction of intracellular calcium via glutamate antagonists, including NMDA and non-NMDA receptor antagonists.
- Application of oxygen radical scavengers to prevent cellular damage.
- Activation of adenosinergic and serotonergic systems to induce neuroprotection through potassium permeability increase.
Main Results:
- Calcium antagonists effectively inhibit calcium influx into neurons.
- Glutamate antagonists modulate intracellular calcium levels by targeting specific receptor-associated channels.
- Oxygen radical scavengers mitigate neuronal damage.
- Adenosinergic and serotonergic agonists promote neuroprotection via membrane hyperpolarization.
Conclusions:
- Targeting calcium homeostasis, excitotoxicity, and oxidative stress are key neuroprotective strategies.
- Pharmacological interventions modulating neurotransmitter systems offer potential therapeutic avenues for ischemic brain injury.